Roberto Muga

3.7k total citations · 1 hit paper
128 papers, 2.3k citations indexed

About

Roberto Muga is a scholar working on Epidemiology, Infectious Diseases and Pathology and Forensic Medicine. According to data from OpenAlex, Roberto Muga has authored 128 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Epidemiology, 37 papers in Infectious Diseases and 33 papers in Pathology and Forensic Medicine. Recurrent topics in Roberto Muga's work include Alcohol Consumption and Health Effects (32 papers), Liver Disease Diagnosis and Treatment (30 papers) and Hepatitis C virus research (29 papers). Roberto Muga is often cited by papers focused on Alcohol Consumption and Health Effects (32 papers), Liver Disease Diagnosis and Treatment (30 papers) and Hepatitis C virus research (29 papers). Roberto Muga collaborates with scholars based in Spain, United States and United Kingdom. Roberto Muga's co-authors include Arantza Sanvisens, Jordi Tor, Daniel Fuster, Ferrán Bolao, Marta Torrens, Celestino Rey‐Joly, Monica E. Parise, Ambrose Misore, A J Oloo and R W Steketee and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Roberto Muga

126 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence

2021 323 citations Roberto Muga et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto Muga Spain	24	1.2k	703	595	531	303	128	2.3k
Barbara Broers Switzerland	19	655 0.5×	310 0.4×	261 0.4×	272 0.5×	128 0.4×	63	1.4k
David M. Novick United States	24	909 0.7×	399 0.6×	203 0.3×	478 0.9×	128 0.4×	53	1.6k
Markus Backmund Germany	24	1.7k 1.4×	332 0.5×	271 0.5×	1.5k 2.9×	79 0.3×	53	2.2k
Jared A. Leff United States	27	836 0.7×	458 0.7×	178 0.3×	383 0.7×	144 0.5×	56	2.3k
Karina M. Berg United States	20	616 0.5×	241 0.3×	754 1.3×	66 0.1×	93 0.3×	41	2.4k
Iain M. Murray‐Lyon United Kingdom	31	1.4k 1.1×	117 0.2×	175 0.3×	1.2k 2.3×	363 1.2×	96	3.2k
Hélène Peyrière France	22	456 0.4×	279 0.4×	537 0.9×	24 0.0×	167 0.6×	116	1.7k
Peter P. Koopmans Netherlands	24	579 0.5×	90 0.1×	1.5k 2.6×	145 0.3×	275 0.9×	54	2.5k
Marta Boffito United Kingdom	37	1.0k 0.9×	254 0.4×	3.4k 5.7×	229 0.4×	628 2.1×	253	4.6k
J Weil United Kingdom	25	683 0.6×	181 0.3×	198 0.3×	191 0.4×	621 2.0×	47	3.2k

Countries citing papers authored by Roberto Muga

Since Specialization

Citations

This map shows the geographic impact of Roberto Muga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Muga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Muga more than expected).

Fields of papers citing papers by Roberto Muga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Muga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Muga. The network helps show where Roberto Muga may publish in the future.

Co-authorship network of co-authors of Roberto Muga

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Muga. A scholar is included among the top collaborators of Roberto Muga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Muga. Roberto Muga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fuster, Daniel, et al.. (2024). Substance use disorder: Epidemiology, medical consequences and treatment. Medicina Clínica (English Edition). 162(9). 431–438. 2 indexed citations

Fuster, Daniel, et al.. (2024). Trastorno por uso de sustancias: epidemiología, complicaciones médicas y tratamiento. Medicina Clínica. 162(9). 431–438. 8 indexed citations

Muga, Roberto, et al.. (2024). Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action. Addiction Science & Clinical Practice. 19(1). 19–19. 10 indexed citations

Navarro, Jordi, Adrián Curran, Berta Raventós, et al.. (2023). Prevalence of non-alcoholic fatty liver disease in a multicentre cohort of people living with HIV in Spain.. European Journal of Internal Medicine. 110. 54–61. 6 indexed citations

García‐Marchena, Nuria, Alberto Marcos, Mario G. Moreno, et al.. (2022). Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex. Biomedicines. 10(5). 1137–1137. 3 indexed citations

Pellegrini, Manuela, Emilia Marchei, Roberta Pacifici, et al.. (2022). New Psychoactive Substances Consumption in Opioid-Use Disorder Patients. Biology. 11(5). 645–645. 5 indexed citations

Fuster, Daniel, et al.. (2020). Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment. Drug and Alcohol Dependence. 216. 108231–108231. 1 indexed citations

Papaseit, Esther, Clara Pérez‐Mañá, Marta Torrens, et al.. (2020). MDMA interactions with pharmaceuticals and drugs of abuse. Expert Opinion on Drug Metabolism & Toxicology. 16(5). 357–369. 18 indexed citations

Sanvisens, Arantza, Gabriel Rubio, Antoni Gual, et al.. (2020). Sex-specific Associations of Alcohol Withdrawal in Patients Admitted for the Treatment of Alcohol Use Disorder. Journal of Addiction Medicine. 15(1). 68–73. 7 indexed citations

10.

Bolao, Ferrán, et al.. (2019). Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL‐6) in Patients Admitted for Alcohol Use Disorder Treatment. Alcoholism Clinical and Experimental Research. 44(1). 152–158. 10 indexed citations

11.

Sanvisens, Arantza, et al.. (2019). Five‐Year Incidence of Hospital‐Based Emergencies Related to Acute Recreational Intoxication in Minors. Alcoholism Clinical and Experimental Research. 43(10). 2179–2186. 4 indexed citations

12.

Alejos, Belén, Inés Suárez‐García, Otilia Bisbal, et al.. (2019). Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors. PLoS ONE. 14(8). e0221598–e0221598. 5 indexed citations

13.

Muga, Roberto, Arantza Sanvisens, Inmaculada Jarrín, et al.. (2018). Hepatitis C infection substantially reduces survival of alcohol-dependent patients. Clinical Epidemiology. Volume 10. 897–905. 8 indexed citations

14.

Fuster, Daniel, et al.. (2018). Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder. Drug and Alcohol Dependence. 190. 195–199. 7 indexed citations

15.

Papaseit, Esther, Marta Torrens, Clara Pérez‐Mañá, Roberto Muga, & Magı́ Farré. (2018). Key interindividual determinants in MDMA pharmacodynamics. Expert Opinion on Drug Metabolism & Toxicology. 14(2). 183–195. 11 indexed citations

16.

Sanvisens, Arantza, Álvaro Muñoz, Ferrán Bolao, et al.. (2018). Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?. Drug and Alcohol Dependence. 188. 180–186. 5 indexed citations

17.

Sanvisens, Arantza, Daniel Fuster, Ferrán Bolao, et al.. (2017). Folate deficiency in patients seeking treatment of alcohol use disorder. Drug and Alcohol Dependence. 180. 417–422. 18 indexed citations

18.

Sanvisens, Arantza, et al.. (2016). Alcohol Consumption during Pregnancy: Analysis of Two Direct Metabolites of Ethanol in Meconium. International Journal of Molecular Sciences. 17(3). 417–417. 7 indexed citations

19.

Sanvisens, Arantza, Aina Teniente‐Serra, Daniel Fuster, et al.. (2016). Wide array of T-cell subpopulation alterations in patients with alcohol use disorders. Drug and Alcohol Dependence. 162. 124–129. 8 indexed citations

20.

Gilchrist, Gail, Klaus Langohr, Francina Fonseca, Roberto Muga, & Marta Torrens. (2012). Factors associated with discharge against medical advice from an alcohol and drug inpatient detoxifcation unit in Barcelona between 1993 and 2006. QRU Quaderns de Recerca en Urbanisme. 14(1). 35–44. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact